Praxis Precision Medicines, Inc.
PRAX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1 | $0 | $0 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $0 | $0 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 249.5% | – | – | – |
| Gross Profit | -$0 | -$0 | -$0 | $0 |
| % Margin | -1,682% | -3,445.8% | – | – |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -2,336.1% | -5,146.8% | – | – |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -2,137.5% | -5,037.9% | – | – |
| EPS Diluted | -10.21 | -18.69 | -69.33 | -58.96 |
| % Growth | 45.4% | 73% | -17.6% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |